Table of Contents
ISRN Gastroenterology
Volume 2012, Article ID 170210, 8 pages
http://dx.doi.org/10.5402/2012/170210
Research Article

Towards Universal Screening for Colon Cancer: A Cheap, Reliable, Noninvasive Test Using Gene Expression Analysis of Rectal Swabs

California Pacific Medical Center Research Institute, San Francisco, CA 49107, USA

Received 16 September 2011; Accepted 18 October 2011

Academic Editor: J.-P. Buts

Copyright © 2012 Andrew P. Smith et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Neugut and B Lebwohl, “Commentary: sigmoidoscopy versus colonoscopy,” Journal of the American Medical Association, vol. 306, p. 34, 2011. View at Google Scholar
  2. D. Steinwachs, J. D. Allen, W. E. Barlow et al., “National Institutes of Health state-of-the-science conference statement: enhancing use and quality of colorectal cancer screening,” Annals of Internal Medicine, vol. 152, no. 10, pp. 663–667, 2010. View at Google Scholar · View at Scopus
  3. T. F. Imperiale, D. F. Ransohoff, S. H. Itzkowitz, B. A. Turnbull, and M. E. Ross, “Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population,” New England Journal of Medicine, vol. 351, no. 26, pp. 2704–2714, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. A. Ahlquist, D. J. Sargent, C. L. Loprinzi et al., “Stool DNA and occult blood testing for screen detection of colorectal neoplasia,” Annals of Internal Medicine, vol. 149, no. 7, pp. 441–450, 2008. View at Google Scholar · View at Scopus
  5. S. Hundt, U. Haug, and H. Brenner, “Blood markers for early detection of colorectal cancer: a systematic review,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 10, pp. 1935–1953, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Sieg, “Colon capsule endoscopy compared with conventional colonoscopy for the detection of colorectal neoplasms,” Expert Review of Medical Devices, vol. 8, no. 2, pp. 257–261, 2011. View at Publisher · View at Google Scholar · View at PubMed
  7. T. C. He, A. B. Sparks, C. Rago et al., “Identification of c-MYC as a target of the APC pathway,” Science, vol. 281, no. 5382, pp. 1509–1512, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. T. J. Koh, C. J. Bulitta, J. V. Fleming, G. J. Dockray, A. Varro, and T. C. Wang, “Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 533–539, 2000. View at Google Scholar · View at Scopus
  9. Z. Zhang and R. N. Dubois, “Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor,” Oncogene, vol. 20, no. 33, pp. 4450–4456, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. C. J. Sherr, “The pezcoller lecture: cancer cell cycles revisited,” Cancer Research, vol. 60, no. 14, pp. 3689–3695, 2000. View at Google Scholar · View at Scopus
  11. D. A. Notterman, U. Alon, A. J. Sierk, and A. J. Levine, “Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays,” Cancer Research, vol. 61, no. 7, pp. 3124–3130, 2001. View at Google Scholar · View at Scopus
  12. L. C. Chen, C. Y. Hao, Y. S. Y. Chiu et al., “Alteration of gene expression in normal-appearing colon mucosa of APC min mice and human cancer patients,” Cancer Research, vol. 64, no. 10, pp. 3694–3700, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Ieda, M. Watatani, T. Yoshida, K. Kuroda, H. Inui, and M. Yasutomi, “Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas,” Surgery Today, vol. 26, no. 4, pp. 230–235, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. C. E. Eberhart, R. J. Coffey, A. Radhika, F. M. Giardiello, S. Ferrenbach, and R. N. Dubois, “Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas,” Gastroenterology, vol. 107, no. 4, pp. 1183–1188, 1994. View at Google Scholar · View at Scopus
  15. A. Li, M. L. Varney, and R. K. Singh, “Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials,” Clinical Cancer Research, vol. 7, no. 10, pp. 3298–3304, 2001. View at Google Scholar · View at Scopus
  16. N. S. Williams, R. B. Gaynor, S. Scoggin et al., “Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference,” Clinical Cancer Research, vol. 9, no. 3, pp. 931–946, 2003. View at Google Scholar · View at Scopus
  17. A. C. J. Polley, F. Mulholland, C. Pin et al., “Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia,” Cancer Research, vol. 66, no. 13, pp. 6553–6562, 2006. View at Publisher · View at Google Scholar · View at PubMed
  18. N. J. Belshaw, G. O. Elliott, R. J. Foxall et al., “Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa,” British Journal of Cancer, vol. 99, no. 1, pp. 136–142, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. N. J. Belshaw, N. Pal, H. S. Tapp et al., “Patterns of DNA methylation in individual colonic crypts reveal aging and cancer-related field defects in the morphologically normal mucosa,” Carcinogenesis, vol. 31, no. 6, pp. 1158–1163, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. J. M. Yi, M. Dhir, L. Van Neste et al., “Genomic and epigenomic integration identifies a prognostic signature in colon cancer,” Clinical Cancer Research, vol. 17, no. 6, pp. 1535–1545, 2011. View at Publisher · View at Google Scholar · View at PubMed
  21. D. Øgreid and E. Hamre, “Stool DNA analysis detects premorphological colorectal neoplasia: a case report,” European Journal of Gastroenterology and Hepatology, vol. 19, no. 8, pp. 725–727, 2007. View at Publisher · View at Google Scholar · View at PubMed
  22. C. Y. Hao, D. H. Moore, Y. S. Y. Chiu et al., “Altered gene expression in normal colonic mucosa of individuals with polyps of the colon,” Diseases of the Colon and Rectum, vol. 48, no. 12, pp. 2329–2335, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. C. Y. Hao, D. H. Moore, P. Wong, J. L. Bennington, N. M. Lee, and L. C. Chen, “Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer,” Clinical Cancer Research, vol. 11, no. 4, pp. 1400–1407, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. F. E. Ahmed, P. Vos, S. IJames et al., “Transcriptomic molecular markers for screening human colon cancer in stool and tissue,” Cancer Genomics and Proteomics, vol. 4, no. 1, pp. 1–20, 2007. View at Google Scholar · View at Scopus